Norlén et al., 1978 - Google Patents
Alpha‐Adrenolytic Treatment in Patients With Autonomous Bladders.Norlén et al., 1978
- Document ID
- 17922890801557504811
- Author
- Norlén L
- Sundin T
- Publication year
- Publication venue
- Acta Pharmacologica et Toxicologica
External Links
Snippet
The effect of alpha‐adrenolytic treatment (phenoxybenzamine) was studied in 8 patients with lower motor neuron lesions (autonomous bladders). In the cystometrograms, the bladders were more hypotonic and the “autonomous waves''appeared at a higher level of …
- 210000003932 Urinary Bladder 0 title abstract description 37
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2210/00—Anatomical parts of the body
- A61M2210/10—Trunk
- A61M2210/1078—Urinary tract
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Detecting, measuring or recording for diagnostic purposes; Identification of persons
- A61B5/48—Other medical applications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Detecting, measuring or recording for diagnostic purposes; Identification of persons
- A61B5/20—Detecting, measuring or recording for diagnostic purposes; Identification of persons for measuring urological functions restricted to the evaluation of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Chang | Urodynamic studies in acupuncture for women with frequency, urgency and dysuria | |
| Abrams et al. | Bladder outflow obstruction treated with phenoxybenzamine | |
| Stewart et al. | Stress incontinence: conservative therapy with sympathomimetic drugs | |
| Holmes et al. | Bladder training—3 years on | |
| Boreham et al. | Alpha‐adrenergic blockers in prostatism | |
| Rossier et al. | Urodynamics in spinal shock patients | |
| Wein et al. | The effects of bethanechol chloride on urodynamic parameters in normal women and in women with significant residual urine volumes | |
| Norlén et al. | Alpha‐Adrenolytic Treatment in Patients With Autonomous Bladders. | |
| Salinas et al. | Urological evaluation in the Shy Drager syndrome | |
| Langworthy et al. | Urethral resistance in relation to vesical activity | |
| Lee | The Clinical Use of Urecholine in Dysfunctions of the Bladder: Preliminary Report | |
| US20230255940A1 (en) | Oxymetazoline for the treatment of ano-rectal disorders | |
| Fossberg et al. | Sensory urgency in females: treatment with phenylpropanolamine | |
| Montague et al. | Urethral pressure profiles before and after Ornade administration in patients with stress urinary incontinence | |
| Sutherst et al. | The effect on the bladder pressure of sudden entry of fluid into the posterior urethra | |
| Vaidyanathan et al. | Beta-adrenergic activity in human proximal urethra: a study with terbutaline | |
| Madersbacher | The neuropathic urethra: urethrogram and pathophysiologic aspects | |
| Alexander et al. | Congenital Lumbosacral Myelomeningocele with Incontinence: A Contribution to the Understanding of Bladder Physiology | |
| Melick et al. | Use of a ureteral pacemaker in the treatment of ureteral reflux | |
| Lapides et al. | Urinary vesicovascular reflex | |
| Draper et al. | The effect of banthine in the treatment of genito-urinary disorders | |
| Melzer | The urecholine test | |
| Nordling et al. | Urinary incontinence in the female. The value of detrusor reflex activation procedures | |
| Jörgensen et al. | Dynamics of the urinary tract during induced vesico-ureteric reflux in pigs. II | |
| Boyd et al. | Why Are Abnormal Cystometrograms Obtained in Normal Patients? |